Riboflavin and UV light treatment of platelets: A protective effect of platelet additive solution?

Transfusion

Volumn 55, Issue 8, 2015, Pages 1900-1908

  Van Der Meer, Pieter F ^a   Bontekoe, Ido J ^a   Daal, Brunette B ^a   De Korte, Dirk ^a  

^a CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; GLUCOSE; LACTIC ACID; LIPOCORTIN 5; PADGEM PROTEIN; RIBOFLAVIN; BICARBONATE; GLUCOSE BLOOD LEVEL; HYPOTONIC SOLUTION; LACTIC ACID DERIVATIVE; PHOSPHATE; SELP PROTEIN, HUMAN; SOLUTION AND SOLUBILITY;

AEROBIC METABOLISM; ARTICLE; BLOOD BUFFY COAT; BLOOD STORAGE; CELL PROTECTION; COMPARATIVE STUDY; CONTROLLED STUDY; FLOW CYTOMETER; GENERAL MEDICAL DEVICE; GLUCOSE INTAKE; HEMATOLOGY ANALYZER; HUMAN; HYPOTONIC SHOCK RESPONSE SCORE; IN VITRO STUDY; LEUKOCYTE COUNT; METABOLIC RATE; OXIDATION; PATHOGEN REDUCTION SYSTEM; PH; PLATELET ADDITIVE SOLUTION; PROTEIN EXPRESSION; SCORING SYSTEM; SOLUTION AND SOLUBILITY; THROMBOCYTE; ULTRAVIOLET RADIATION; ANALYSIS; BLOOD; BLOOD SAFETY; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; METABOLISM; OSMOTIC PRESSURE; PLASMA; PROCEDURES; RADIATION RESPONSE; THROMBOCYTE ACTIVATION;

ANNEXIN A5; BICARBONATES; BLOOD GLUCOSE; BLOOD PLATELETS; BLOOD PRESERVATION; BLOOD SAFETY; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOTONIC SOLUTIONS; LACTATES; OSMOTIC PRESSURE; P-SELECTIN; PHOSPHATES; PLASMA; PLATELET ACTIVATION; RIBOFLAVIN; SOLUTIONS; ULTRAVIOLET RAYS;

EID: 84938954524     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13033     Document Type: Article

References (36)

1. Dwyre DM, Fernando LP, Holl PV,. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sang 2011; 100: 92-8.
2. Alter HJ,. Pathogen reduction: a precautionary principle paradigm. Transfus Med Rev 2008; 22: 97-102.
3. Fast LD, DiLeone G, Marschner S,. Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation. Transfusion 2011; 51: 1397-404.
4. Asano H, Lee CY, Fox-Talbot K, et al., Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants. Transplantation 2007; 84: 1174-82.
5. Goodrich RP, Gilmour D, Hovenga N, et al., A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns. Transfusion 2009; 49: 1205-16.
6. AuBuchon JP, Herschel L, Roger J, et al., Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion 2005; 45: 1335-41.
7. Mirasol Clinical Evaluation Study Group. A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology. Transfusion 2010; 50: 2362-75.
8. Azuma H, Hirayama J, Akino M, et al., Platelet additive solution-electrolytes. Transfus Apher Sci 2011; 44: 277-81.
9. Murphy S, Sayar SN, Gardner FH,. Storage of platelet concentrates at 22 degrees C. Blood 1970; 35: 549-57.
10. Fijnheer R, Veldman HA, van den Eertwegh AJ, et al., In vitro evaluation of buffy-coat-derived platelet concentrates stored in a synthetic medium. Vox Sang 1991; 60: 16-22.
11. Bertolini F, Murphy S, Rebulla P, et al., Role of acetate during platelet storage in a synthetic medium. Transfusion 1992; 32: 152-6.
12. van der Meer PF, Kerkhoffs JL, Curvers J, et al., In vitro comparison of platelet storage in plasma and in four platelet additive solutions, and the effect of pathogen reduction: a proposal for an in vitro rating system. Vox Sang 2010; 98: 517-24.
13. de Wildt-Eggen J, Schrijver JG, Bins M, et al., Storage of platelets in additive solutions: effects of magnesium and/or potassium. Transfusion 2002; 42: 76-80.
14. Tardivel R, Vasse J, Gaucheron S, et al., A comparative study of the efficiency of plasma and additive solution preserved platelet concentrates [abstract]. Vox Sang 2012; 103 (Suppl 1): 247.
15. Holme S, Moroff G, Murphy S,. A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Transfusion 1998; 38: 31-40.
16. VandenBroeke T, Dumont LJ, Hunter S, et al., Platelet storage solution affects on the accuracy of laboratory tests for platelet function: a multi-laboratory study. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Vox Sang 2004; 86: 183-8.
17. Verhoeven AJ, Verhaar R, Gouwerok EG, et al., The mitochondrial membrane potential in human platelets: a sensitive parameter for platelet quality. Transfusion 2005; 45: 82-9.
18. Pietersz RN, de Korte D, Reesink HW, et al., Preparation of leukocyte-poor platelet concentrates from buffy coats. III. Effect of leukocyte contamination on storage conditions. Vox Sang 1988; 55: 14-20.
19. De Korte D, editor. Richtlijn bloedproducten [Guideline blood products]. 6th ed. Amsterdam: Sanquin Blood Supply; 2013.
20. Fung MK, Grossman BJ, Hillyer C, Westhoff CM, editors. Technical manual. 18th ed. Bethesda (MD): American Association of Blood Banks; 2014.
21. Ruane PH, Edrich R, Gampp D, et al., Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004; 44: 877-85.
22. Li J, de Korte D, Woolum MD, et al., Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products. Vox Sang 2004; 87: 82-90.
23. Li J, Lockerbie O, de Korte D, et al., Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology. Transfusion 2005; 45: 920-6.
24. Picker SM, Steisel A, Gathof BS,. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units. Transfusion 2008; 48: 1685-92.
25. Picker SM, Tauszig ME, Gathof BS,. Cell quality of apheresis-derived platelets treated with riboflavin-ultraviolet light after resuspension in platelet additive solution. Transfusion 2012; 52: 510-6.
26. Cookson P, Thomas S, Marschner S, et al., In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days. Transfusion 2012; 52: 983-94.
27. Gyulkhandanyan AV, Mutlu A, Freedman J, et al., Selective triggering of platelet apoptosis, platelet activation or both. Br J Haematol 2013; 161: 245-54.
28. Leytin V,. Apoptosis in the anucleate platelet. Blood Rev 2012; 26: 51-63.
29. Cadet J, Decarroz C, Wang SY, et al., Mechanisms and products of photosensitized degradation of nucleic acids and related model compounds. Isr J Chem 1983; 23: 420-9.
30. Holme S, Moroff G, Whitley P, et al., Properties of platelet concentrates prepared after extended whole blood holding time. Transfusion 1989; 29: 689-92.
31. Keuren JF, Cauwenberghs S, Heeremans J, et al., Platelet ADP response deteriorates in synthetic storage media. Transfusion 2006; 46: 204-12.
32. Middelburg RA, Roest M, Ham J, et al., Flow cytometric assessment of agonist-induced P-selectin expression as a measure of platelet quality in stored platelet concentrates. Transfusion 2013; 53: 1780-7.
33. Zeddies S, De Cuyper IM, van der Meer PF, et al., Pathogen reduction treatment using riboflavin and ultraviolet light impairs platelet reactivity toward specific agonists in vitro. Transfusion 2014; 54: 2292-300.
34. Slichter SJ, Corson J, Jones MK, et al., Exploratory studies of extended storage of apheresis platelets in a platelet additive solution (PAS). Blood 2014; 123: 271-80.
35. Keil SD, Hansen E, Gilmour DI, et al., Treatment of platelet products in additive solution with riboflavin and UV light: effectiveness against bacterial contamination [abstract]. Transfusion 2009; 39 (Suppl): 227A.
36. Keil SD, Bengrine A, Bowen R, et al., Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment. Transfusion 2015; 55: 000-00.